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As the recipient of the 2011 SC Governor's Award for Excellence in Scientific Research, I've been
asked to describe my research and some of the accomplishments of my laboratory while at the
University of South Carolina. My research is focused on understanding the structure and function
of the pore-forming proteins of the human"complement system", and in particular complement
protein "C8". The complement system is a group of blood proteins that have a key role in immune
defense. Much of what is known today about the structure and function of human C8 can be
attributed to work performed over many years by my graduate students and postdoctoral fellows.

Introduction The human "complement system" is composed of
approximately 35 different proteins, enzymes, receptors and
regulatory molecules found primarily in blood. The system is
referred to as complement because it "complements" or
enhances the ability of the immune system to defend against
pathogens, e.g. bacteria, viruses, etc. The system is
"activated" either by the interaction of complement proteins
with antibody-antigen complexes (classical pathway) or by
interaction with the unusual carbohydrate found on the surface
of pathogenic (non-self) organisms (lectin and alternative
pathways). Each activation pathway leads to the "terminal
pathway" and formation of the end-product of complement
activation. This end-product is the "membrane attack
complex" of complement or "MAC", a large (~106 kDa)
complex composed of complement proteins C5b, C6, C7, C8
and multiple copies of C9 (1-4). The MAC kills bacteria by
forming a pore or "hole" in the bacterial cell membrane.
The sequence of interactions leading to MAC formation is
well defined; however, the mechanism by which the MAC
disrupts membrane organization is poorly understood. MAC
assembly begins with local production of C5b by activated
complement (Fig. 1). This is followed by binding of C6 to
form a soluble, noncovalently-linked C5b-6 complex.
Subsequent binding of C7 produces an amphiphilic complex
(C5b-7) that has an affinity for cell membranes. C5b-7 binds
to the outer portion of membrane bilayers and only minimally
penetrates the interior. Once on the membrane, C5b-7 binds
C8 and forms a tetrameric C5b-8 complex. The ultrastructure
of C5b-8 has no pore-like features; however, this complex
causes leakage of synthetic lipid vesicles, increases ionconductance in planar lipid bilayers, and promotes the slow
osmotic lysis of simple cells such as heterologous
erythrocytes. Photolabeling studies using membrane-restricted
probes identified the C8α subunit as the major C5b-8
component inserted in the membrane (5). In the final step of
MAC formation, C5b-8 binds and initiates the selfpolymerization of C9 to form a cylindrical transmembrane
pore composed of 12-18 C9 molecules (poly C9) (3,6). On
bacteria, the MAC increases outer membrane permeability,
which in turn induces lethal changes in the inner membrane.
Other than proteolytic cleavage of C5, all steps leading to
MAC formation are nonenzymatic and the protein interactions

are all noncovalent.
Individually, the five MAC components circulate in blood
as hydrophilic proteins, but when combined they form an
amphiphilic complex capable of intercalating into cell
membranes. The MAC does not degrade membrane lipid but
instead produces a disruptive rearrangement that causes
osmotic lysis of simple cells such as erythrocytes, initiates
intracellular signaling events in nucleated cells, and disrupts
the outer membrane of bacteria. Our own cells contain CD59,
a membrane-anchored protein that protects us from
complement-mediated damage by preventing assembly of a
functional MAC.
The MAC components interact in a highly specific and
sequential manner once C5b is formed. As each intermediate
complex is formed, binding specificity changes and is directed
towards the next component incorporated. Once associated,
the affinity between components is high despite the
noncovalent nature of their interactions. Dissociation can only
be accomplished by solubilization of the membrane and
denaturation of the MAC. The goal of our program has been
to identify structural features that specify the order in which
these proteins bind, and the mechanism by which they
undergo a hydrophilic to amphiphilic transition that enables
them to bind to lipid. Our strategy has been to focus on
identifying structure-function relationships in one component,
namely human C8, and thereby gain insight into how the other
MAC components function. Understanding how the MAC is
assembled and its function may lead to the development of
therapeutic pore-forming analogues that could be used to
attack undesirable human cells, e.g. cancer cells.

The MAC Family Proteins
Human C5b contains two disulfide-linked subunits and is
the largest MAC protein (180 kDa). C6, C7 and C9 are single
chain proteins of approximately 105 kDa, 92 kDa and 72 kDa,
respectively. C8 (151 kDa) is the most complex in that it is
composed of three nonidentical, genetically distinct subunits
(α = 64 kDa; β = 64 kDa and γ = 22 kDa) (7). These subunits
are arranged as a disulfide-linked C8α-γ heterodimer that is
noncovalently associated with C8β. The affinity between C8αγ and C8β is high. Dissociation can only be achieved using
denaturing agents or high ionic strength buffers.
Our discovery in the 1980's that each C8 subunit was
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Fig. 1 Assembly of the Membrane Attack Complex (MAC). The components and sequence of interactions are described in the text. The inset
shows an EM of a typical membrane pore formed by poly C9 within the MAC.

encoded in a different gene was significant because C8 was
thought to be a single gene product, i.e. synthesized as a
single-chain precursor that was posttranslationally cleaved.
This discovery came as we were characterizing human liver
cDNA clones to determine the amino acid sequence of C8 (8).
The results established that C8 was composed of three
different proteins rather than one. Our efforts to determine the
sequences and genomic organization of C8 together with the
work of others provided the first evidence of a structural and
evolutionary relationship between the MAC proteins.
Human C6, C7, C8α, C8β, and C9 are homologous and
together form the "MAC family" of proteins. Family members
exhibit sequence similarity and have a highly conserved
modular organization (Fig. 2) (4,9). Their genomic structures
are also similar with respect to exon length and boundaries. A
distinctive feature of each is the presence of cysteine-rich Nand C-terminal modules that are ~40–80 amino acids in
length. The modules exhibit sequence similarity to those
found in a variety of proteins unrelated to complement.
Although not considered a module, the central portion of each
protein (~ 40 kDa) is designated MACPF to emphasize its
conservation among the MAC proteins and its sequence
similarity to perforin, a 70 kDa pore-forming protein released
from secretory granules of cytotoxic T lymphocytes.
The conserved organization of the MAC proteins initially
suggested the modules themselves may mediate proteinprotein interactions during MAC assembly. This was
consistent with the view that the MAC can be thought of as a
"heteropolymer" formed from structurally similar but distinct
monomeric units. Also noteworthy was the fact these modules
mediate protein-protein interactions in other systems. MAC
assembly requires binding interactions that are highly ordered
and the question of whether specificity is determined by

differences in fine-structure of the modules or sequence
variations within the MACPF domains was important to
answer.

Properties of Human C8
Our focus on C8 has provided valuable insight into the
specificity of interactions between the MAC components and
their ability to undergo a hydrophilic to amphiphilic
transition. Unlike the other MAC proteins, C8 occurs in
blood as a complex of C8α-γ and C8β. Our abilityto purify C8
in large quantities from blood, dissociate C8α-γ from C8β,
and separate C8α from C8γ has allowed the assignment of
individual roles for these subunits in MAC formation and
function. Results indicate each subunit performs multiple
binding functions. Extending these findings to the next level
of detail, i.e. localizing the binding regions in each subunit,
has been particularly challenging. The large size and number
of disulfide linkages within C8α and C8β has limited our
ability to produce and manipulate these proteins using
recombinant DNA technology, i.e. bacterial or eukaryotic
expression systems. Nevertheless, we succeeded in narrowing
the location of sites in each subunit that are involved in
several key binding interactions.

Binding Sites on C8α
C8α contains several binding sites (Fig. 3). One mediates
interaction between C8α-γ and C8β to form C8. C8α also has
a site that recognizes C8γ and facilitates the biosynthetic
assembly of C8α-γ. Within C5b-8, C8α functions to bind and
direct C9 into the MAC. C8α is also recognized by CD59, a
complement regulatory protein that protects human cells by
binding C8α and C9 and inhibiting formation of the MAC.
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Fig. 2 The MAC Family Proteins. Modules and other structural features of each protein are described in the inset. All cysteines form intrachain
disulfide bonds except C164 in C8α that is linked to C40 in C8γ. Residue numbers identify module boundaries.

noncovalent binding to C8β in the absence of C8γ (11).
Together, these results suggested that binding of C8α-γ to C8β
is mediated strictly by C8α.
This was confirmed when the C8α MACPF domain was
shown to contain the binding site for C8β. The MACPF
segment of C8α (αMACPF) was coexpressed with C8γ in
COS cells and formed a disulfide-linked αMACPF-γ dimer
(12). Assays showed the secreted dimer had the ability to bind
C8β. Subsequently, we succeeded in producing the C8α
MACPF domain alone in large quantities in E.coli and showed
that it also can bind C8β with high affinity (13). This
established unequivocally that the principal binding site for
C8β lies within the C8α MACPF domain.
Fig. 3 Location of Binding sites on C8α and C8β. Residue numbers
identify segments containing binding sites for the indicated proteins.

C8α also contributes to the cytolytic activity of the MAC by
interacting directly with membrane lipid. These interactions
occur simultaneously during MAC formation; therefore they
were assumed to involve physically distinct, nonoverlapping
sites. The following summarizes our progress towards
assigning these binding functions to specific regions of C8α.
C8β Binding Site
Binding between C8α and C8β was initially observed using
C8α that was purified after cleavage of the interchain
disulfide in C8α-γ (10). C8α bound C8β to form a 1:1
complex in solution. Subsequent studies used recombinant
full-length C8α produced in baculovirus to demonstrate

C8γ Binding Site
Although C8α occurs as a disulfide-linked heterodimer with
C8γ, it retains the ability to interact noncovalently with C8γ
after cleavage of the interchain disulfide bond. Such binding
has also been observed with recombinant forms of C8α and
C8γ in which the linking Cys residues have been deleted (12).
These observations and the fact that biosynthetic processing in
the liver hepatocyte requires noncovalent association prior to
disulfide bond formation indicates C8α and C8γ contain
mutually recognizable binding sites.
The location of the C8γ binding site within the MACPF of
C8α was suggested from a comparative analysis of MACPF
sequences in C6, C7, C8α, C8β, and C9. The C8α MACPF
sequence is distinctive in that it contains a unique indel
(insertion/deletion) between residues 159-175, which includes
C164 that forms the disulfide bond to C40 in C8γ. Indels in
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homologous proteins frequently correspond to loops and are
often regions of functional significance; therefore this
segment of C8α was considered a possible C8γ binding site.
The indel was examined for its ability to mediate binding of
C8γ by using a chimeric form of C8β as a substitute for C8α
(14). Insertion of the C8α indel sequence into C8β and
coexpression of this chimera with C8γ in COS cells produced
an atypical disulfide-linked C8β-γ dimer. These results
unequivocally established that intracellular binding of C8γ to
C8α is mediated solely by residues within the C8α indel.
C9 Binding Site
One function of C8 is to mediate incorporation of the first
C9 into the MAC. C9 has little affinity for C5b-6 or C5b-7 but
readily binds to C5b-8. Such binding induces an apparent
conformational change in the first C9 that initiates selfpolymerization and formation of poly C9. Studies using
purified C8 and C9 have shown that these proteins can form a
1:1 complex in solution (15,16).
Binding between C8 and C9 is mediated principally by
C8α. Interaction between C9 and C8α-γ or C8α can be
demonstrated over a range of ionic strengths whereas binding
to C8β or C8γ is negligible. C8α when combined with C8β
exhibits both hemolytic and bactericidal activity in the
presence of C9 (11,17). Thus, C8α is the key component for
binding and incorporation of C9 into the MAC.
In an effort to locate the C9 binding site on C8α, truncated
and chimeric C8α in which modules were deleted or
exchanged for those in C8β were expressed independently or
as heterodimers with C8γ and combined with C8β. Initial
studies used COS cells for low level expression and then later
used E. coli to express larger quantities of αMACPF or
αMACPF-γ for purification and characterization (13). These
were tested for their ability to bind C9 in solution and express
hemolytic activity. Collectively, the results showed that
binding between C8 and C9 is dependent on a site located
within the C8α MACPF domain.
CD59 Binding Site
MAC formation is regulated in part by the binding of CD59
to C8. Human CD59 is a 20-kDa membrane-bound
complement regulatory protein that protects human blood and
vascular cells from damage by complement. Analysis of the
physical association of CD59 with components of the MAC
indicated C8α contains a binding site for CD59 (18). A series
of studies using recombinant human-rabbit C8 chimeric
proteins eatablished that CD59 binds to a conformationally
sensitive site on C8α that is centered on residues 334-385
(19). This binding interferes with the normal assembly of the
MAC and thereby protects our own cells from random MAC
formation and damage.
Lipid Binding Site
C8α contains one or more lipid binding sites that become
exposed within the MAC. Evidence for this comes from
photolabeling studies using membrane-restricted probes to
identify components of the MAC that are inserted into the
bilayer (5). In both C5b-8 and the MAC, extensive labeling of

C8α suggests it is inserted into the lipid bilayer, and that it
contributes significantly to membrane perturbation. In the
MAC, C9 is also heavily labeled, consistent with its role in
forming poly C9 and the pore-like structure of the MAC.

Binding Sites on C8β
C8β also contains several binding sites (Fig. 3). One site
mediates binding to C8α in C8α-γ. A second site mediates
incorporation of C8 into the MAC. C8β alone has a high
affinity for C5b-7 and carries the structural epitope(s)
recognized by this complex. Because C8β can simultaneously
interact with C8α-γ and C5b-7, the respective binding sites
must be physically distinct. Within the MAC, C8β also has the
capacity to associate with lipid. Photolabeling experiments
indicate C8β is in contact with the bilayer, although to a lesser
extent than C8α or C9.
C8α Binding Site
To localize the C8α binding region, C8β constructs were
prepared in which the N- and/or C-terminal modules were
deleted or exchanged with the corresponding modules in C8α.
These were expressed recombinantly and the products tested
for binding to C8α-γ. Results initially suggested a role for the
N-terminal T1 module and MACPF domain but later studies
using recombinant C8β MACPF expressed in E. coli revealed
that the binding site for C8α resides entirely within the C8β
MACPF domain (20,21).
C5b-7 Binding Site
Binding of C8 to C5b-7 is essentially irreversible;
dissociation can only be accomplished by denaturing the
resulting C5b-8 complex. Binding studies using purified C8
subunits revealed that C8β and C8 have a comparable affinity
for C5b-7 (22). Furthermore, C8β effectively blocks C8
incorporation into the MAC; therefore it must compete for the
same binding site on C5b-7. To identify the portion of C8β
recognized by C5b-7, truncated recombinant C8β constructs
were combined with C8α-γ and assayed for their ability to
associate with C5b-7 and express C8 hemolytic activity (20).
Assays were limited to constructs that bind C8α-γ because
C8α is required for C9 binding. Constructs that contained only
the C8β MACPF domain when combined with C8α-γ were
found to be hemolytically active, thus confirming that the
C5b-7 binding site in C8β lies within its MACPF domain (21).

Properties and Structure of C8γ
Although its structure is well characterized, the function of
C8γ in the complement system remains elusive. Over the
years, several possibilities have been considered but
subsequently discounted by studies performed in our
laboratory (reviewed in ref 23). C8γ is not required for the
synthesis and secretion of C8α; C8α can be expressed
independently as a recombinant protein in mammalian and
insect cells. Binding between C8α-γ and C8β is likewise not
dependent on C8γ; purified C8α and C8β can form a 1:1
complex in the absence of C8γ. C8γ is also not essential for
incorporation of C8 into the MAC nor is it required for MAC
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cytolytic activity. Although not as efficient, a complex of C8α
+ C8β is an effective substitute for C8 in the MAC-mediated
lysis of simple cells such as erythrocytes and in the killing of
gram-negative bacteria (11,17).
C8γ is structurally unrelated to any complement protein; it
is a member of the lipocalin family of proteins that have the
common ability to bind small hydrophobic ligands, e.g.
retinol, fatty acids, steroids, pheromones, etc (24-26).
Lipocalins exhibit little sequence similarity yet have a highly
conserved fold. The core structure consists of an eightstranded antiparallel β-barrel that resembles a calyx or cupshaped structure with a binding pocket for a small molecule.
Residues lining the interior of the calyx and the size of the
calyx vary among family members, thus lipocalins exhibit
different ligand specificities.
To gain insight into the identity of a putative ligand for
C8γ, we produced human recombinant C8γ in insect cells and
solved the crystal structure to 1.2 Å resolution (27). C8γ
displays a typical lipocalin β-barrel fold with a potential
ligand binding site. Although it has a similar fold, C8γ differs
from most lipocalins in that its binding pocket is divided into
a hydrophillic upper portion and an unusually large, lower
hydrophobic cavity. Access to the lower cavity is restricted by
the close proximity of two tyrosine side chains. The entrance
to the lower cavity is narrow; however it is accessible to a
ligand if there is movement of the tyrosines. This was shown
in crystallographic studies using lauric acid as a ligand;
movement of the tyrosine side chains allowed the alkyl
portion of laurate to penetrate into the lower cavity (28). The
features of the binding pocket suggest that any natural ligand
for C8γ will have a narrow hydrophobic moiety at one end
and a negatively charged group at the other end.
Related studies indicate C8γ may not normally bind a small
molecule ligand. C8γ was co-crystallized with a 19-residue
synthetic peptide encoding the C8α indel that binds C8γ (29).
The crystal structure showed the indel peptide completely
filling the upper portion of the C8γ ligand binding pocket and
in contact with all four loops at the calyx entrance. Binding
studies performed with the peptide in solution suggested the
C8γ ligand binding site is also blocked by the indel segment
of C8α within C8. This was later confirmed when structures
of αMACPF-γ and C8 (see below) showed that access to the
C8γ ligand binding site would require a major conformational
change to move the C8α indel away from the calyx entrance.

αMACPF and the Pore-Forming Bacterial
Cholesterol Dependent Cytolysins (CDCs)
One of the most significant advances in our understanding
of the MAC came about as a result of our ability to produce
the ~40 kDa αMACPF domain on a large scale in E. coli.
Bacteria often do not form the correct disulfide bonds in
recombinantly expressed proteins. We found that E.coli can
not only produce a soluble, functional αMACPF domain with
the correct disulfide bonds but also a disulfide-linked dimer of
αMACPF and C8γ (αMACPF-γ) when a dual expression
vector is used to simultaneously express both proteins (13).
Recombinant αMACPF and αMACPF-γ were purified and

found to be functional. Our results showed unequivocally that
the αMACPF domain contains the binding sites for C8β and
C9. Most importantly, production of αMACPF and αMACPFγ on a large scale enabled our laboratory and others to
crystallize these fragments and obtain the first detailed
structural information for a human MAC family protein.
Insight into how MAC proteins insert into membranes came
when x-ray crystal structures were simultaneously reported
for the MACPF-containing protein PluMACPF, and human
recombinant αMACPF that was generated by our methods
E.coli (30,31). Importantly, these proteins were found to
display a fold similar to the pore-forming bacterial CDCs.
This was subsequently confirmed when we determined the
crystal structure of αMACPF-γ (32). CDCs are virulent poreforming proteins secreted from gram positive bacteria and
used to invade eukaryotic cells (33). The mechanism of pore
formation by CDC proteins is well understood. 30-50 CDC
monomers self-polymerize on cholesterol-rich regions of the
eukaryotic cell surface to form a circular "pre-pore", which
upon completion inserts into the membrane as a functional
pore (34). This process involves a concerted conformational
change whereby two regions of each CDC monomer, which
are initially in an α-helical conformation, refold into an
extended conformation and insert into the bilayer as two
amphipathic β-hairpins (TMH). TMHs from neighboring
molecules “share edges” of their β-hairpins to form a
hydrogen-bonded transmembrane β-barrel.
Figure 4 compares the structure of αMACPF-γ to
intermedilysin (ILY), a well-characterized CDC from
Streptococcus intermedius (35). Key similarities in the core
structures include the overall size, the presence of a central βsheet, and two α-helical bundles that in ILY refold into
amphipathic β-hairpins. In the CDCs, refolding of the TMH1
and TMH2 helical bundles to form β-hairpins is accompanied
by elongation of the core β-sheet and alignment with a
neighboring monomer (36,37). The striking structural
similarity between complement MACPF proteins and the
CDCs suggests that complement uses a CDC-like mechanism
for pore formation.

Structure of Human C8 and a Model of the MAC
Pore
A major milestone was reached in 2011 when we published
the x-ray crystal structure of whole C8 purified from blood
(38). This is the first complete structure of a MAC family
protein and of a protein containing two tightly associated
MACPF domains. The large size of C8 and its intrinsic
flexibility made it particularly challenging to crystallize and
solve the structure, a project that required many years to
complete. Not surprisingly, C8α-γ and C8β have many of the
same CDC-like features seen initially in αMACPF-γ. The
sequence of C9 is 27% and 26% identical to the corresponding
regions of C8α and C8β, respectively, thus C9 likely has a
fold similar to these two subunits and the CDCs.
The structure of C8 is shown in Fig. 5. The central part of
the C8α and C8β MACPF domains form large, four-stranded,
antiparallel β-sheets with a bend and twist in the middle,
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Fig. 4 Comparison of the αMACPF-γ and Intermedilysin (ILY)
Structures. Shown are ribbon models of αMACPF-γ and ILY. The
core β-sheet is in blue, the two α-helical bundles (TMH1 and TMH2)
known to re-fold into β-hairpins in ILY and predicted to do so in
αMACPF are in red. C8γ is green and the cholesterol-binding domain
in ILY is lavender. Other structural elements are gold. As predicted
from earlier studies, the entrance to the C8γ β-barrel is occupied by a
large loop containing the indel segment of αMACPF.

which gives them a “Γ” shape. Their lower part is flanked by
the TMH α-helical bundles. Together with another helix they
form the "lower" MACPF subdomain. The upper part of the
sheet and helices surrounding it forms the “upper” subdomain,
which makes contacts with the modules, and most likely with
other MAC proteins. The relative positions of the C8α and
C8β MACPF subdomains differ as a result of a different bend
and twist in their central β-sheets. The upper MACPF
subdomains form very thin, tabular structures tightly packed
together with the β-sheets facing one another in C8. These
interactions are likely responsible for the strong binding
between C8α-γ and C8β. The lower subdomains differ in that
the sheets are not facing one another but are nearly coplanar; a
small gap between them shows no edge sharing. Separation of
the lower subdomains could facilitate refolding of the TMHs
during insertion into membranes whereas the tightly packed
upper subdomains are unlikely to change their relative
position and may have a role in directing and maintaining the
circular shape of the pore.
In CDCs, during transition from pre-pore to pore, the bend
in the central β-sheet is reduced, the sheet changes from the
“Γ” shape to a “ ” shape, and the TMHs refold from an αhelical to an extended conformation, thus elongating the
central β-sheet and allowing insertion of THMs into the
membrane. This transition requires a large movement between
the upper and lower subdomains and is thought to be
facilitated by four glycines located at the bend of the central
β-sheets (37). These residues are conserved in C8α and C8β
and likely have a similar role in refolding of the MACPF
domains.
The oligomeric C8 structure has provided valuable insight
into how the MAC components interact to form a circular

Fig. 5 Structure of Human C8. Upper panel is a ribbon model of C8
showing C8α (red), C8β (blue), and C8γ (green). MACPF domains
are in dark colors, modules in light. Lower panel shows separate
views of C8α-γ and C8β oriented as in the upper panel. The central
MACPF β-sheet is blue, α-helices in TMH1 and TMH2 are red, and
the remainder of the MACPF domain is gold. The modules are
located on the periphery of C8 and are lavender.

pore. Athough the structure is of a pair of MACPF proteins in
a "non-pore" state, the unusual geometrical relationship
between C8α and C8β has important functional implications.
Most frequently, homodimeric proteins are related by a 180°
rotation. By contrast, C8α and C8β are related by a rotation of
22°, while the translation between their centers is almost
perpendicular to the rotation axis, resulting in only a small
(1.6 Å) translational component parallel to the rotation axis. It
is well established that C8 mediates the binding and
incorporation of C9 into the MAC, and that this involves a
specific C9 binding site within the C8α MACPF domain.
Assuming the modes of binding between C9 and C8α and
between C9 and C9 are similar to that between C8α and C8β,
with no translational component, we constructed a model for
the C8-C9 complex (Fig. 6A). To do this, a homology model
of C9 was generated based on C8α and rotated (~22°)
according to the geometrical relationship between C8α and
C8β. Rotations of the C9 model by multiplicities of 22°
yielded the positions of further C9 molecules and resulted in
a model for the circular MAC pore (Fig. 6B, 6C). The inner
diameter of the ring is 110 Å, the outer diameter is ~ 220 Å,
and the height is 90 Å. This agrees well with EM images of
pores formed by poly C9, which generally have dimensions of
~ 100 Å and 210 Å for the inner and outer diameters,
respectively. Also, our pore model contains 16 molecules per
ring, in excellent agreement with low resolution EM studies of
pores formed by MAC and poly C9 (3,6).
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by bacteria and other lower organisms to make holes in our
cells. What remains now is to decipher the details of that
mechanism. This will require a detailed analysis of the
structure and function of C6, C7 and C9, which will now be
facilitated by the progress we have made on C8.
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